A Randomized Controlled Trial of a Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
Stanford University
Summary
The goal of this randomized clinical trial is to be adequately powered to evaluate the effect of ketogenic metabolic therapy on the quality of life in serious mental illness, schizophrenia, bipolar disorder, major depressive disorder.
Description
The ketogenic diet is a low carbohydrate, moderate protein, higher fat diet to help individuals improve energy and mood and to obtain nutrients from fats and protein. Schizophrenia, bipolar disorder, and major depressive disorder, collectively affect about 344 million individuals worldwide, (24 million with schizophrenia, 40 million people with BD, and 280 million with depression World Health Organization). These illnesses are debilitating psychiatric conditions characterized by a chronic pattern of emotional, behavioral, and cognitive disturbances. Shared psychopathology includes the pre-emin…
Eligibility
- Age range
- 18–80 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. diagnosed with bipolar disorder (BD), major depressive disorder (MDD), and or schizophrenia 1. For individuals diagnosed with bipolar disorder (BD): * Meet DSM V criteria for BD (any subtype) * Not mild * \>40 on BPRS * clinically stable (with no hospitalization for past 3 months) 2. For individuals diagnosed with major depressive disorder (MDD): * Not mild * PHQ-9 \> 10 * clinically stable (with no hospitalization for past 3 months) 3. For individuals diagnosed with schizophrenia: * Meet DSM V criteria for sc…
Interventions
- OtherLCHF Ketogenic Diet
Low Carbohydrate, Moderate Protein, High Fat (LCHF) Ketogenic Dietary Intervention for 12 weeks
- OtherDiet-as-Usual (DAU)
Participant's usual diet
Location
- Stanford UniversityPalo Alto, California